Neoplasm Staging

"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.

Descriptor ID	D009367
MeSH Number(s)	E01.789.625
Concept/Terms	Neoplasm Staging Neoplasm Staging Staging, Neoplasm Tumor Staging Staging, Tumor Cancer Staging Staging, Cancer TNM Staging TNM Staging Staging, TNM TNM Staging System Staging System, TNM Staging Systems, TNM System, TNM Staging Systems, TNM Staging TNM Staging Systems TNM Classification Classification, TNM Classifications, TNM TNM Classifications

Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Prognosis [E01.789]
Neoplasm Staging [E01.789.625]

Below are MeSH descriptors whose meaning is related to "Neoplasm Staging".

Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.

Bar chart showing 821 publications over 30 distinct years, with a maximum of 47 publications in 2014 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	12	12
1997	1	13	14
1998	0	16	16
1999	2	16	18
2000	0	24	24
2001	1	15	16
2002	1	20	21
2003	2	28	30
2004	2	21	23
2005	0	30	30
2006	1	24	25
2007	0	34	34
2008	1	33	34
2009	0	30	30
2010	3	36	39
2011	0	38	38
2012	1	39	40
2013	2	41	43
2014	1	46	47
2015	0	23	23
2016	0	43	43
2017	4	38	42
2018	8	39	47
2019	5	28	33
2020	2	27	29
2021	0	20	20
2022	0	16	16
2023	0	12	12
2024	6	15	21
2025	0	1	1

Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.

Gaillard S, Lacchetti C, Armstrong DK, Cliby WA, Edelson MI, Garcia AA, Ghebre RG, Gressel GM, Lesnock JL, Meyer LA, Moore KN, O'Cearbhaill RE, Olawaiye AB, Salani R, Sparacio D, van Driel WJ, Tew WP. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update. J Clin Oncol. 2025 03; 43(7):868-891.

View in: PubMed
Matei DE, Enserro DM, Randall ME, Mutch D, Small W, DiSilvestro PA, Spirtos NM, O'Malley DM, Cantuaria GH, Michelin D, Waggoner S, Shahin M, Guntupalli S, Lara O, Ueland FR, Warshal D, Bonebrake A, Tewari KS, Tan A, Powell MA, Walker JL, Santin AD, Kim JH, Miller DS. Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma. J Clin Oncol. 2025 03 20; 43(9):1055-1060.

View in: PubMed
Geynisman DM, Abbosh PH, Ross E, Zibelman MR, Ghatalia P, Anari F, Mark JR, Stamatakis L, Hoffman-Censits JH, Viterbo R, Greenberg RE, Churilla TM, Horwitz EM, Hallman MA, Smaldone MC, Uzzo R, Chen DYT, Kutikov A, Plimack ER. Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1). J Clin Oncol. 2025 03 20; 43(9):1113-1122.

View in: PubMed
Bhutiani N, Hu CY, Palis B, Cotler J, Shi Q, Washington MK, Goldberg RM, Steele SR, Chang GJ. Lack of Hierarchical Survival Prognosis in AJCC Staging for Colon and Rectal Cancer-Implications for Future Summary Stage Classification. Clin Colorectal Cancer. 2025 06; 24(2):159-165.e2.

View in: PubMed
Brown JC, Ma C, Shi Q, Couture F, Kuebler P, Kumar P, Tan B, Krishnamurthi S, Chang V, Goldberg RM, O'Reilly EM, Shields AF, Meyerhardt JA. Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B-Southwest Oncology Group 80702 (Alliance). J Natl Cancer Inst. 2024 12 01; 116(12):2032-2039.

View in: PubMed
Shore ND, Morgans AK, Tutrone RF. Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancer. Future Oncol. 2024 Dec; 20(39):3179-3182.

View in: PubMed
Shore ND, Cookson MS, Efstathiou E. The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer. Future Oncol. 2024 Dec; 20(40):3351-3354.

View in: PubMed
Whitehorn GL, Rshaidat H, Madeka I, Martin J, Mack SJ, Meredith L, Alaparthi S, Grenda TR, Evans NR, Okusanya OT. Lobectomy Is Not Associated With Improved Survival as Compared to Segmentectomy in Early-Stage Lung Cancer Patients With Visceral Pleural Invasion. Clin Lung Cancer. 2025 Mar; 26(2):e99-e107.e10.

View in: PubMed
Montagna G, Laws A, Ferrucci M, Mrdutt MM, Sun SX, Bademler S, Balbaloglu H, Balint-Lahat N, Banys-Paluchowski M, Barrio AV, Benson J, Bese N, Boughey JC, Boyle MK, Diego EJ, Eden C, Eller R, Goldschmidt M, Hlavin C, Heidinger M, Jelinska J, Karadeniz Cakmak G, Kesmodel SB, King TA, Kuerer HM, Loesch J, Milardi F, Murawa D, Moo TA, Menes TS, Passeri D, Pastoriza JM, Perhavec A, Pislar N, Polidorio N, Rami A, Ryu JM, Schulz A, Sevilimedu V, Ugurlu MU, Uras C, van Hemert A, Wong SM, Yoo TR, Zhang JQ, Karanlik H, Cabioglu N, Peeters MV, Morrow M, Weber WP. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study. J Clin Oncol. 2025 03; 43(7):810-820.

View in: PubMed
La Cerda J, Thorley J, Sieber P, Cookson MS, Flanders SC, Gatoulis SC, Shore ND. Plain language review: the safety of relugolix combination therapy for advanced prostate cancer. Future Oncol. 2025 Jan; 21(1):51-62.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement